up to now couple of years, the UK has witnessed a revolution in clinical fat‑reduction treatments — from the introduction of semaglutide (Wegovy®) towards the developing popularity of tirzepatide (Mounjaro®). Now, Yet another title is drawing awareness in both clinical and public health and fitness circles: Retatrutide. at this time under en